trx0014
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00515333)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trx0014
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00684944 | Phase 2 | Jul 1, 2007 | Queen Elizabeth Hospital NHS Foundation Trust, TauRx Therapeutics Ltd |
| NCT00515333 | Phase 2 | Aug 1, 2004 | Queen Elizabeth Hospital NHS Foundation Trust, TauRx Therapeutics Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Queen Elizabeth Hospital NHS Foundation Trust | Academic/Hospital | 2 | 0 | 1 | 2004 |
| TauRx Therapeutics Ltd | For profit | 2 | 2 | 1 | 2004 |
2 organizations
Page 1 / 1